These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11511100)

  • 1. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.
    Li X; Josef J; Marasco WA
    Biochem Biophys Res Commun; 2001 Aug; 286(3):587-94. PubMed ID: 11511100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation.
    Kretz-Remy C; Bates EE; Arrigo AP
    J Biol Chem; 1998 Feb; 273(6):3180-91. PubMed ID: 9452429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD; Morris CB; Offermann MK
    Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha.
    Kabouridis PS; Hasan M; Newson J; Gilroy DW; Lawrence T
    J Immunol; 2002 Sep; 169(5):2587-93. PubMed ID: 12193729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.
    Demarchi F; d'Adda di Fagagna F; Falaschi A; Giacca M
    J Virol; 1996 Jul; 70(7):4427-37. PubMed ID: 8676466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins.
    Blázquez MV; Macho A; Ortiz C; Lucena C; López-Cabrera M; Sánchez-Madrid F; Muñoz E
    AIDS Res Hum Retroviruses; 1999 Sep; 15(13):1209-18. PubMed ID: 10480634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H; Tarnok J; Parks WP
    J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds.
    Lee R; Beauparlant P; Elford H; Ponka P; Hiscott J
    Virology; 1997 Aug; 234(2):277-90. PubMed ID: 9268159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
    J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide inhibits HIV tat-induced NF-kappaB activation.
    Chen F; Lu Y; Castranova V; Rojanasakul Y; Miyahara K; Shizuta Y; Vallyathan V; Shi X; Demers LM
    Am J Pathol; 1999 Jul; 155(1):275-84. PubMed ID: 10393859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
    J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.
    Macián F; Rao A
    Mol Cell Biol; 1999 May; 19(5):3645-53. PubMed ID: 10207088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S phase dependence and involvement of NF-kappaB activating kinase to NF-kappaB activation by camptothecin.
    Habraken Y; Piret B; Piette J
    Biochem Pharmacol; 2001 Sep; 62(5):603-16. PubMed ID: 11585057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.